Patent EP0128009A2 successfully refreshed from Google Patents.
EP0128009A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Synergistic composition comprising gamma interferon and lymphotoxin, and its preparation
Assignee: Genentech Inc
•
Filing: 1984-05-31
•
Granted: —
•
Expires: 2004-05-31
Abstract
Abstract The present invention pertains to synergistic compositions comprising human iymphotoxin and human gamma interferon which potentiate one another in inhibiting tumor growth.
Inventors
- 👤 Bharat Bhushan Aggarwal
- 👤 Sang He Lee
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-04 14:00
CPC Classifications
A; A61; A61K; A61K45/00; A61K38/00; A61K38/16; A61K38/17; A61K38/19; A61K38/21; A61K38/217
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
10 words
A composition comprising HuIFN-γ and HLT in synergistically effective amounts.
Claim 2
Dependent Claim
10 words
A composition comprising HuIFN-γ and HLT in synergistically effective amounts.
Claim 3
Dependent Claim
14 words
The composition of Claim I in admixture with at least one pharmaceutically acceptable excipient.
Claim 4
Dependent Claim
12 words
The. composition of Claim 1 or 2 which is prepared in vitro.
Claim 5
Dependent Claim
24 words
The composition of Claim 1 or 2 which is prepared by administering at least portions of HLT and HuIFN-y separately to a subject mammal.
Claim 6
Dependent Claim
15 words
The composition of Claim 1-4 wherein the HuIFN-y active ingredient is substantially free of impurities.
Claim 7
Dependent Claim
15 words
The composition of Claim 1-4 wherein the HLT active ingredient is substantially free of impurities.
Claim 8
Dependent Claim
19 words
A process for producing a composition having synergistic biological effect comprising combining synergistically potentiating amounts of HuIFN-y and HLT.
Claim 9
Dependent Claim
19 words
A process for producing a composition having synergistic biological effect comprising combining synergistically potentiating amounts of HuIFN-y and HLT.
Claim 10
Dependent Claim
13 words
The process of Claim 7 wherein said combining is carried out in vitro.
Claim 11
Dependent Claim
13 words
The process of Claim 7 wherein said combining is carried out in vivo.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.